ScholarIQanswers from OpenAlex & ORCID
Keyue Ding
ResearcherPublications, citations & collaboration network
Keyue Ding is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Keyue Ding have?
ScholarIQindexed works
Keyue Ding has 316 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Keyue Ding have?
ScholarIQcitation count
Keyue Ding has 25,849 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Keyue Ding?
ScholarIQh-index
Keyue Ding has an h-index of 58 in OpenAlex.
What is the i10-index of Keyue Ding?
ScholarIQi10-index
Keyue Ding has an i10-index of 151 in OpenAlex.
What is the ORCID of Keyue Ding?
ScholarIQorcid
The ORCID for Keyue Ding is on the source record.
What is the OpenAlex record for Keyue Ding?
ScholarIQopenalex
The OpenAlex for Keyue Ding is on the source record.
What are the most-cited papers on Keyue Ding?
ScholarIQmost cited works
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen Spiro, Estelle Rolland, Roldano Fossati, D. Aubert, Keyue Ding, David Waller, Thierry Le Chevalier
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang‐Qi Zhu, Suzanne Kamel‐Reid, Jeremy A. Squire, Ian Lorimer, Tong Zhang, Geoffrey Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain E. Lagarde, Frank C. Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph L. Pater, Frances A. Shepherd
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Timothy Winton, Robert B. Livingston, David C. Johnson, James R. Rigas, Michael Johnston, Charles Butts, Yvon Cormier, Glenwood Goss, Richard Inculet, Eric Vallières, Willard A. Fry, Drew Bethune, Joseph Ayoub, Keyue Ding, Lesley Seymour, Barbara Graham, Ming‐Sound Tsao, David R. Gandara, Kenneth A. Kesler, Todd L. Demmy, Frances A. Shepherd
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden, Jeremy M. G. Taylor, David E. Misek, Andrew C. Chang, Samir Hanash, Rork Kuick, David G. Beer, Steven A. Enkemann, Timothy J. Yeatman, Steven A. Eschrich, Michael E. Gruidl, Anupama Sharma, Tsao Ml, Igor Jurišica, Chang‐Qi Zhu, Daniel Strumpf, Frances A. Shepherd, William L. Gerald, János Szőke, Maureen F. Zakowski, Valerie W. Rusch, Mark G. Kris, Agnès Viale, Noriko Motoi, William D. Travis, Thomas J. Giordano, Keyue Ding, Lesley Seymour, Katsuhiko Naoki, Nathan A. Pennell, Barbara A. Weir, Roel Verhaak, M. Meyerson, Christine Ladd‐Acosta, Todd R. Golub, Barbara Conley, Venkatraman Seshan, Kevin K. Dobbin, Tracy Lively, James W. Jacobson
Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study
Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer, Ming‐Sound Tsao, Gregory A. Masters, James R. Jett, Martin J. Edelman, Rogério Lilenbaum, Hak Choy, Fadlo R. Khuri, Katherine M.W. Pisters, David R. Gandara, Kemp H. Kernstine, Charles Butts, Jonathan Noble, Thomas A. Hensing, Kendrith M. Rowland, Joan H. Schiller, Keyue Ding, Frances A. Shepherd